Pharmacokinetics, Pharmacodynamics and Tolerability of a Potent, Non-Peptidic, GP IIb/IIIa Receptor Antagonist Following Multiple Oral Administrations of a Prodrug Form

Thrombosis and Haemostasis - Germany
doi 10.1055/s-0037-1614238